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ABSTRACT 
Mycotoxins are ubiquitous, mold- 
produced toxins that contaminate a wide 
variety of foods and feeds. Ingestion of 
mycotoxins cause a range of toxic 
responses, from acute toxicity to long- 
term or chronic health disorders. Some 
mycotoxins have caused outbreaks of hu- 
man toxicoses, and at least one 
mycotoxin, aflatoxin B1, is a presumed 
human hepatocarcinogen. As part of a 
comprehensive effort to curtail the ad- 
verse health effects posed by mycotox- 
ins, substantial research has been con- 
ducted to determine the mechanism of 
action of mycotoxins in animals. This 
review presents some of the current 
knowledge on the biological action of 
four diverse classes of mycotoxins- 
aflatoxin B1, tricothecenes, zearalenone, 
and fumonisin B1-with particular em- 
phasis on mechanisms of action. 
(Key words: mycotoxin, mold, toxicity, 
biological action) 
Abbreviation key: AF = aflatoxin (also used 
with B1, MI, Q1, and PI), AFB1-FAPyr = 
AFB 1-formamidopyrimidine adduct, AFBI- 
W-Gua = AFB1-N7-guanine adduct, AFL = 
aflatoxicol (used with HI and MI), ELEM = 
equine leukoencephalomalacia, FBI = fumoni- 
sin B1, GSH = glutathione, HCC = hepatocel- 
lular carcinoma, ZEN = zearalenone, yGT+ = 
y-glutamyl-transpeptidase- positive. 
INTRODUCTION 
Thousands of natural toxins exist that have 
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known or potential adverse health effects in 
humans and animals. Natural toxins have been 
termed “nature’s pesticides” because they often 
confer a protective or competitive advantage to 
the organism or plant that produces them (2). 
Because the diet contains at least 10,000 times 
more natural toxins exist compared with syn- 
thetic toxins (manmade toxins, such as pesti- 
cides or environmental chemicals), natural tox- 
ins probably pose the greater threat to human 
and animal health (1). One large group of 
natural toxins that are nearly universal con- 
taminants of food and feed are the mycotoxins, 
the toxic secondary metabolites produced by 
fungi. 
Mycotoxins are a diverse group of chemi- 
cals that elicit a wide range of toxic responses 
in animals and humans. he-  or postharvest 
contamination of various food crops by 
mycotoxigenic fungi is a common problem; 
approximately 25% of the world’s food supply 
is contaminated by mycotoxins annually (19). 
The severity of mycotoxin contamination of 
agricultural commodities varies yearly. Exces- 
sive moisture in the field and in storage, tem- 
perature extremes, humidity, drought, varia- 
tions in harvesting practices, and insect 
infestation are major environmental factors 
that determine the severity of mycotoxin con- 
tamination. Although the actual resultant eco- 
nomic loss to agriculture is difficult to deter- 
mine with accuracy, it is likely to be high. 
In domestic animals, such as dairy cattle, 
swine, and poultry, mycotoxin contamination 
reduces growth efficiency, lowers feed conver- 
sion and reproductive rates, impairs resistance 
to infectious diseases, reduces vaccination ef- 
ficacy, and induces pathologic damage to the 
liver and other organs. Many mycotoxins have 
been implicated in outbreaks of human dis- 
eases. Some are potent animal, and presumed 
human, carcinogens. For these reasons, 
mycotoxins pose a major threat to public and 
animal health, and determination of the biolog- 
ical mechanism of action of mycotoxins has 
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understandably been the focus of much re- 
search. The biological action of four classes of 
mycotoxins that represent diverse toxicities to 
animals-aflatoxin (AF)B 1, tricothecenes, 
zearalenone (ZEN), and fumonisin B1 (FBI)- 
are considered in this overview. 
AFB1 
Aflatoxin B1 (Figure 1) represents a group 
of mycotoxins produced by strains Aspergillus 
jlavus and Aspergillus parasiticus. Of the 
known mycotoxins, AFBl had generated the 
greatest concern and has stimulated the most 
research effort because of its extreme toxicity 
and its widespread Occurrence in staple foods 
and feeds (such as peanuts, corn, and cotton- 
seed). For these reasons, AFBl currently is the 
only mycotoxin that is regulated by the FDA. 
In foods, the current “action level” (the con- 
centration above which the commodity is con- 
demned) is 20 ppb of total AF. The action 
level for the AFB1 metabolite AFMl in milk is 
.5 ppb. Other regulatory guidelines for AFB1 
include 20 ppb in corn for dairy cows, 300 ppb 
in corn for finishing beef cattle and swine, and 
100 ppb for breeding stock (24). The permissi- 
ble amount of AFB1 in cottonseed for beef 
cattle, swine, and poultry is 300 ppb (55). 
These regulatory levels generally preclude de- 
tectable AFBl in the various products from 
these animals. Worldwide, established toler- 
ances for A F B l  in animal feeds range from 10 
to 600 ppb (65). 
Prevention of Aspergillus infection in foods 
and feeds is the most desirable method of 
reducing AFB1, although AFBl contamination 
often is unavoidable, even with the best 
agricultural practices. Therefore, several strate- 
gies have been developed to reduce postharvest 
product contamination of AFB1. Some of these 
methods involve early identification and segre- 
gation of grossly contaminated kernels of corn 
or peanuts or use of electronic devices to iden- 
tify and to reject grains that exhibit fluores- 
cence that is due to AFB1. Although these 
methods have been useful for peanuts, they 
have not been practical for decontaminating 
corn and cottonseed (54). Ammoniation has 
shown considerable promise as a means of 
treating contaminated cottonseed and corn be- 
cause it can be used to treat large batches of 
product, and, importantly, ammoniation results 
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Figure I .  Chemical structure of atlatoxin (AF) AFBl 
and DNA adducts of AFBI, AFB1-V-guanine and for- 
mamidopyrimidine (AFBI-FAPyr). 
in nearly complete elimination of AF and as- 
sociated toxicity in commodities (54). Am- 
moniation has not yet achieved FDA approval 
for interstate shipments, but it is in use in 
some states. Another experimental strategy is 
the use of inorganic absorbent feed additives, 
which prevent absorption of mycotoxins in 
animals. For example, when added to feeds 
contaminated by AFB1, hydrated sodium cal- 
cium aluminosilicate, an anticaking agent ap- 
proved by the FDA, significantly reduced bi- 
oavailability of AFBl and many of the AFB1- 
specific toxic effects in pigs (14). 
A requisite step in the toxic and carcino- 
genic action of AFBl is its conversion to a 
variety of metabolites (Figure 2). Metabolism 
of A F B l  is mediated principally by hepatic and 
extrahepatic microsomal cytochromes P-450, 
although other conversions have also been 
described (16). Most of the metabolic products 
are less toxic than parent AFB1, the most 
prevalent of which is AFM1, so named for its 
appearance in the milk of dairy cows that 
consume feed contaminated by AFB1. Other 
detoxified metabolites produced from the P- 
450 oxidation of AFBl include AFQl and 
AFPl  (Figure 2). 
Aflatoxin B1 also is reduced by soluble 
NADPH-dependent cytosolic enzymes to pro- 
duce aflatoxicol (AFL). Because this reaction 
is reversible, AFL may be a storage form of 
AFBl (56). The chronic and acute toxicity of 
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Figure 2. Metabolic scheme of aflatoxin B1. The solid lines represent known pathways; the dashed lines signify 
presumed or proposed pathways 
AFL is equal to that of AFB1; thus, this 
metabolite is not considered to be a detoxified 
metabolite. Furthermore, the mutagenic 
potency of AFL is nearly equal to that of 
AFBl (17). Two minor and relatively nontoxic 
reduced pentanone metabolites also exist, 
AFL-M1 and AFL-HI. The former metabolite 
also may be formed by the cytosolic reduction 
Aflatoxin B1 also is metabolized by 
cytochromes P-450 to the reputed proximate 
carcinogen, the AFB 1-8,g-epoxide. Presumably 
because of its extreme reactivity, the AFBI- 
8,9-epoxide has been isolated only indirectly 
from biological systems as adducts of 
glutathione (GSH) or DNA bases. The AFB1- 
8,9-epoxide can be inactivated by GSH, a reac- 
tion catalyzed by GSH S-transferase. Inactiva- 
tion by GSH is an important AFBl detoxifica- 
tion pathway in a number of species, and the 
formation of AFB1-GSH protects against the 
hepatocarcinogenic effects of AFBl (22, 43). 
Detoxification mediated by GST may be an 
important determinant in species resistance to 
AFB1. Aflatoxin B1 also may be detoxified via 
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of AFMl (64). 
conjugation with sulfates and glucuronic acid 
(11). The AFB1-8,9-epoxide also may be cata- 
lytically (by epoxide hydrolase) or spontane- 
ously hydrolyzed to the AFB 1-8,9-dihydrodiol. 
The carcinogenic and mutagenic action of 
AFBl probably is a result of the affinity of the 
electrophilic and highly reactive AFB1-8,9- 
epoxide for cellular nucleophiles, such as 
DNA. Activated AFBl binds exclusively to 
guanyl residues, and the AFB1-N7-guanine ad- 
duct (AFB1-fl-Gua) is the most predominant 
(Figure 1). Other adducts have been isolated, 
of which the “ring-opened” derivative of 
AFB1-N7-Gua, AFB1-formamidopyrimidine 
(AFB1-FAPyr), is the most common (Figure 
1). In hepatic DNA from livers of rats injected 
with AFB1, approximately 80% of the adducts 
present are AFB1-N7-Gua, whereas the AF’BI- 
FAPyr constitutes approximately 7% (23). The 
formation of these adducts is the presumed 
first step in the development of heritable muta- 
tions from which tumors may arise. Repair of 
these genetic lesions occurs in living cells 
enzymatically or spontaneously, and the re- 
moved adducts is excreted in the urine. 
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The ring-opened adduct appears to be more 
resistant to DNA repair enzymes. In rats 
treated with a single dose of AFB1, the AFB1- 
N7-Gua was rapidly removed with an apparent 
half-life of 7.5 h, whereas other adducts, such 
as AFBI-FAPyr, were removed much more 
Alkylation of DNA with AFBl also may 
result in  the loss of a DNA base, resulting in 
an “apurinic site”. In synthetic oligomers 
treated with AFB1, at least twice as many 
apurinic sites were detected as AFB1-N7-Gua 
(1 3). Which of these genetic lesions ultimately 
is responsible for the carcinogenic action of 
AFBl is not known. Microsomally activated 
AFBl induced GC is converted to TA transver- 
sions in a strain of Escherichia coli, presuma- 
bly as a result of AFBi-N7-Gua formation 
(26). In any event, AFB1-specific mutations 
also exist in cellular protooncogenes and other 
loci in tumors from animals treated with AFB1 
(67). 
The metabolism of AFJ31, specifically the 
balance between activation and detoxification 
pathways in an animal, and the formation and 
repair of genetic lesions induced by this 
mycotoxin appear to be critical determinants of 
species sensitivity. Specific relationships have 
been derived from a number of comparative 
studies in which sensitive species (rat and rain- 
bow trout) have been compared with resistant 
species (mouse and salmon) with respect to 
endpoints that define these processes. For ex- 
ample, the in vivo binding of AFBl to hepatic 
DNA was 40 times greater in the rat than in 
the more resistant moslse (45). A likely mecha- 
nism underlying the relative resistance of the 
mouse is that it efficiently detoxifies the 
AFB1-8.9-epoxide via GSH S-transferase (50). 
Toxic effects of AFBl are either acute or 
chronic, depending in large part on the dose 
and duration of exposure. Aflatoxin B1 is 
acutely toxic to a number of cell types, plants, 
invertebrates, and various vertebrate species. 
Cattle, swine, and poultry are the farm animals 
primarily affected by AFBI. Common observa- 
tions 1 to 2 d following acute exposure to 
AFBl include malaise, loss of appetite, and 
eventually lower growth rates. Because many 
of these sequelae are not specific for AF, field 
diagnoses often are difficult. Approximately .2 
ppm of AFBl causes reduced weight gains in 
cattle, swine, and poultry; between 2 and 10 
slowly (20). 
ppm of AFBl resulted in decreased egg 
production, hepatic necrosis, hemorrhage, and 
death in poultry (57). 
In the bovine, acute AFBl decreased rumen 
motility (31). In a review on that subject, 
studies were described showing that AFBl 
reduced cellulose breakdown and production of 
VFA and ammonia either in vivo or in artifi- 
cial rumen environments (47). Decreases in 
feed conversions, breeding efficiency, and milk 
production and health problems resulted when 
a dairy herd was exposed chronically to corn 
contaminated by AF at 120 ppb (31). 
The liver is the organ most severely af- 
fected by AFBj, and the primary lesions in- 
clude hemorrhagic necrosis, fatty infiltration, 
and bile duct proliferation. In pigs, guinea 
pigs, and dogs, these effects most commonly 
occur in the centrilobular region, whereas in 
ducklings and rats, the periportal region is the 
site of action. Acute toxicities for AFBl have 
been tabulated extensively (1 1). In vertebrate 
species, at least a 10-fold variation occurs in 
susceptibility to the acute effects of AFB1, and 
no species appear to be totally resistant. Poul- 
try, rainbow trout, and monkeys are particu- 
larly sensitive to the acute effects of AFBI; 
oral median lethal doses are .34 to .56, 3.0, and 
.81 mgkg, respectively. The mouse, hamster, 
and rat are much less sensitive; these species 
have oral median lethal doses of 9.0, 10.2, and 
1.3 mgkg, respectively (56). Significant differ- 
ences occurred in potency of AFBl in age, 
strain, gender, and route of administration. 
Aflatoxin B1 is carcinogenic in a wide vari- 
ety of animals. As is the case following acute 
exposures, the major target organ is the liver, 
although tumors in other organs result from 
long-term dietary exposure to AFB1. Aflatoxin 
B1 at .4 ppb fed over 14 mo resulted in a 14% 
incidence of hepatocellular carcinomas (HCC) 
in rainbow trout, the animal species known to 
be most sensitive to the carcinogenic effects of 
this mycotoxin (42). By contrast, tumor inci- 
dence was only 5% during a similar time in 
Fischer rats exposed to 5 ppm of AFBl (83). 
Considerable epidemiological data also sup- 
port the hypothesis that dietary AFBl is an 
important risk factor for human HCC. In many 
geographical areas where incidence of HCC is 
high, such as sub-Saharan Africa and South- 
east Asia, a linear relationship exists between 
AFBl contamination of food and the incidence 
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of HCC (78). However, a firm determination 
of the role of AFBl in human cancer is con- 
founded by the coincidence of hepatitis B virus 
infection, which is another reputed factor for 
HCC in humans in these regions. Further con- 
firming evidence on the role of AFBl in HCC 
has been obtained through the use of new, 
sensitive methods to detect specific “biomar- 
kers” of human exposure to AFB1, such as 
adducts of DNA (3, 30), or serum albumin 
(63). Measurement of these biomarkers in sam- 
ples of blood or urine has allowed direct deter- 
mination of actual AFBl exposure in popula- 
tions, which is an improvement over random 
dietary analysis for AFB1 and imprecise die- 
tary recall surveys. Thus, the use of biomar- 
kers should significantly improve AFBl risk 
assessment. 
Although the majority of interest in the 
possible health effects has correctly focused on 
dietary exposure to AFBl, workers in food and 
grain production and in harvest, transport, and 
processing industries also are exposed to con- 
siderable amounts of airborne, respirable grain 
dusts contaminated by AFB 1. For example, 
airborne dust sampled in a corn processing 
plant contained 107 ng/m3 AFB1, and the daily 
occupational exposure to this toxin was esti- 
mated to be between 40 and 856 ng (10). In 
another survey, concentrations of AFB1 in 
smaller, more easily retained airborne grain 
particles, contained more AFB1 than that in 
larger grain particles; AFBl in particles under 
7 pm were as high as 1814 ppb, whereas 
AFB1, ranging from 7 to 11 pm had an aver- 
age of 695 ppb (69). 
A small number of studies indicate that 
exposure to airborne AFBl may adversely af- 
fect health of those exposed. For example, 
airborne peanut dust contaminated with AFBl 
was linked to increases in liver and lung can- 
cer in Dutch peanut processing workers rela- 
tive to unexposed cohorts (35). An earlier sur- 
vey established that these workers were 
exposed continually to between .04 and 2.5 pg 
of AFBl/wk (77). In laboratory studies, AFBl 
was converted to stable metabolites and acti- 
vated to mutagenic and DNA binding inter- 
mediates by cells of the mammalian respira- 
tory epithelium (5,  6, 18). In cultured airway 
epithelia from a variet of mammalian species, 
AFBl forms AFB1-NY-Gua and AFBI-FAPyr 
in patterns similar to those in hepatic systems 
(6).  
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TRICOTHECENES 
Tricothecenes are a group of over 150 struc- 
turally related compounds produced by several 
genera of fungi, the most important being 
Fusarium. Fusarium sporotrichioides and 
Fusarium graminearum are the most common 
tricothecene producers. In this country, 
tricothecenes commonly infect corn grown in 
the upper Midwest. Low temperatures, high 
moisture, and humidity appear to increase 
toxin production. Tricothecenes possess the 
tetracyclic 12,13-epoxy-tricothecane skeleton 
of the sesquiterpenoids (75). Examples of im- 
portant tricothecenes include T-2 toxin, 
nivalenol, and deoxynivalenol (Figure 3). Of 
these compounds, T-2 toxin has been the most 
widely studied, because it was one of the first 
tricothecenes discovered in grains, although 
deoxynivalenol (vomitoxin) is the most com- 
mon contaminant of cereal grains such as 
wheat and barley in many countries worldwide 
(74). 
The toxic potency of several tricothecenes 
in laboratory animals has been tabulated (74, 
75). The most acutely toxic tricothecene, ver- 
rucarin J, had a median lethal dose of .5 mgkg 
i.v. in mice. In mice, toxin T-2 and nivalenol 
are nearly equitoxic; median lethal doses are 
5.2 and 4.1 mgkg (i.p.), respectively. The in 
vivo toxicity of T-2 toxin and nivalenol are 
approximately 10 times that of deoxynivalenol. 
In a variety of in vitro systems, T-2 consis- 
tently has been the most toxic, followed by 
nivalenol and then deoxynivalenol (75). 
The tricothecenes produce a wide variety of 
toxic effects: acute tricothecene toxicity is 
characterized by gastrointestinal disturbances, 
such as vomiting, diarrhea, and inflammation. 
Dermal irritation, feed refusal, abortion, and 
hematological sequelae, such as anemia and 
leukopenia, also are common. In cattle, dietary 
T-2 toxin at .64 ppm for 20 d resulted in death 
and bloody feces, enteritis, and abomasal and 
ruminal ulcers (57). In poultry, as low as 5 
ppm of tricothecenes resulted in oral necrosis 
and reduced BW gains (12). Egg production 
and shell quality were decreased when poultry 
were fed a diet of 20 ppm of T-2 toxin (57). 
Tricothecenes also are toxic when administered 
dermally. Toxic reactions, which were similar 
to those observed when the tricothecenes were 
administered systematically, were observed 
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when applied doses ranged from IO-" mol follows a multistage pathogenesis. Shortly af- 
(for T-2 toxin, vermcarin A) to lW7 mol ter ingestion of contaminated cereal grains, a 
(deoxynivalenol) (75). burning sensation in the mouth, tongue, throat, 
Alimentary toxic aleukia, which is the most esophagus, and stomach and gastrointestinal 
common human tricothecene mycotoxicosis, disturbances are the initial observations (66). A 
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R= COCyCH(C02H)CH2C02H 
FUMONISIN B1 
Figure 3. Chemical structures of T-2 toxin, nivalenol, deoxynivalenol, zearalenone, and fumonisin B1. AC = Acetate. 
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severe leukopenia and granulopenia may then 
follow, which may progress to white cell 
counts as low as 100 cells/pI of blood (66). 
Continuous exposure to trichothecenes then 
results in rashes on the skin, which may pro- 
gress to severe necrotic lesions. 
The actual mechanisms of these toxic ac- 
tions of the tricothecenes are not clear. Investi- 
gators studying the mechanisms of toxicity 
thus far have focused on the effects of these 
mycotoxins on protein and macromolecular 
synthesis, membrane function, and immune 
parameters. Ueno et al. (76) initially observed 
that a number of tricothecene mycotoxins in- 
hibited protein synthesis in eukaryotic cells. 
The toxin inhibited all steps in protein synthe- 
sis (initiation, elongation, and termination) in 
intact ribosomes (2 1). Structure-activity studies 
indicated that the C-4 or C-5 positions or the 
isovaleryl group at the C-8 position of T-2 
were important for inhibition of protein syn- 
thesis in vitro because h s  mycotoxin was 
more potent than HT-2, neosolaniol, or T-2 
tetrol (72). A substituent at the C-3 position to 
T-2, such as an acetyl group, making acetyl T- 
2 for example, resulted in a diminution of 
inhibition of in vitro protein synthesis. Protein 
synthesis inhibition likely is a result of binding 
of the toxin to ribosomes. The binding of T-2 
to ribosomes is specific and saturable (.3 nM), 
and the stoichiometry is one toxin molecule 
bound per ribosome (48). 
Because T-2 toxin is an amphipathic mole- 
cule, it could be incorporated into the lipid or 
protein moieties of cellular plasma membranes, 
thereby interfering with membrane function 
(59). The in vitro treatment of L-6 myoblasts 
with 8.5 x 10-12 M T-2 toxin reduced the 
uptake of Ca, glucose, Leu, and Tyr within 10 
min of exposure (9). These effects were in- 
dependent of protein synthesis inhibition. Ef- 
fects were similar for erythrocytes treated with 
T-2 but at a much higher concentration (32). 
Recently, human fibroblasts exposed to T-2 (1 
pLIM) accumulated lucifer yellow dye to the 
same extent as control cells, indicating that T-2 
had no effect on membrane function, at least 
with respect to this indicator (40). 
The toxin significantly alters several im- 
mune parameters, and the major effects appear 
to be associated with the cellular immune re- 
sponse, specifically including inhibition of the 
mitogen response, reductions of protein, DNA, 
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and interleukin-2 synthesis in normal spleen 
cells treated with concanavalin A (73), thymic 
atrophy (60, 74), and reductions in plaque- 
forming spleen cells (73). In animals, resis- 
tance to many challenges that are dependent on 
cellular immune-response was decreased, such 
as resistance to mycobacterial infections and 
skin grafts in mice (37, 61), Salmonella in 
mice (71), and aspergillosis in rabbits (52). 
The effects of tricothecenes on the immune 
system have been reviewed recently (66). 
ZEN 
Zearalenone is a phenolic resorcyclic acid 
lactone (Figure 3) produced by strains of 
Fusarium, primarily by F. graminearurn, F. 
sporotrichiodes, and others. Zearalenone is a 
natural contaminant of corn, wheat, barley, 
oats, sorghum, and hay. Toxin production is 
promoted by high humidity and low tempera- 
tures, as is common in the upper Midwest 
during autumn harvest. Zearalenone is a nearly 
universal corn contaminant and often occurs in 
the same samples with tricothecenes (44). De- 
spite its dissimilarity to steroid compounds, 
ZEN produces potent hyperestrogenic 
responses in susceptible animals. Thus, the 
toxicity of this compound is unique among 
known mycotoxins. 
Swine are most affected by ZEN, but other 
animals, such as cattle, poultry, and laboratory 
animals, are also affected, but to a lesser de- 
gree. Symptoms of ZEN poisoning include 
uterine enlargement and swollen vulva and 
mammae (51). In pigs, symptoms of hyperes- 
trogenism generally appear when contamina- 
tion of ZEN in corn exceeds 1 ppm, but it can 
occur at concentrations as low as .1 ppm (49). 
In ewes, ZEN exposure resulted in declines in 
ovulation rate and cycle length and an increase 
in duration of estrus but did not affect preg- 
nancy rate or embryonic loss (68). Young male 
pigs exposed to ZEN undergo symptoms of 
“feminization”, such as enlarged nipples and 
testicular atrophy (51). 
Dairy heifers exposed to ZEN have reduced 
conception rates (19). However, transmission 
of ZEN or its metabolites into milk appears to 
be minimal (58). In rats, decreased growth 
rate, food intake, fertility, resorptions, still- 
births, abortion, and bone malformations in 
fetuses also are sequelae of ZEN ingestion at 
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10 mgkg (4). Egg production in hens is 
reduced by ZEN (8). 
Zearalenone elicits permanent reproductive 
tract alterations. In newborn female mice, ZEN 
treatment (1 pg/d for 5 d) resulted in signifi- 
cant ovary-dependent reproductive tract altera- 
tions at 8 mo posttreatment: the majority of 
treated mice lacked corpus lutea and uterine 
glands and exhibited squamous metaplasia of 
the uterine luminal epithelium (81). Ovariec- 
tomized mice treated with ZEN showed none 
of these ovary-dependent alterations. 
The mechanisms of the estrogenic effect of 
ZEN appears to be mediated via binding of 
this mycotoxin or its metabolites to the 
cytoplasmic estrogen receptor. Trans- and cis- 
ZEN and two ZEN derivatives competed with 
17P-estradiol for binding with the cytosolic 
receptor in rat uterine tissue (41). In that study, 
the binding affinity of ZEN to the receptors 
was only .1 that of estradiol. Translocation of 
the ZEN receptor complex into immature rat 
uterine nuclei induced synthesis of a protein 
with identical properties to that following 
translocation of natural estrogen receptor (38). 
Interestingly, ZEN appears to have a greater 
affinity for estrogen receptors from animals 
that are more susceptible to the estrogenic 
effects of the mycotoxin. The affinity of ZEN 
to uterine and oviduct estrogen receptors fol- 
lowed this order: pig, rat, and chicken (25). 
FUMONlSlNS 
A group of mycotoxins that were discov- 
ered recently have been associated with toxic- 
ity and mortality in horses and pigs following 
ingestion of corn-based feeds that were con- 
taminated by Fusaria. One such animal disease 
is the neurotoxic syndrome equine leukoen- 
cephalomalacia (ELEM). The ELEM syn- 
drome often is epizootic and almost always is 
associated with ingestion of moldy corn. Re- 
search on the possible effects of Fusarium 
contamination of foods and feeds began in 
earnest following initial laboratory studies 
showing that cultures of Fusarium 
monilifomze, the most common fungal con- 
taminant of corn, caused cancer in rats (36). 
Shortly thereafter, a group of compounds 
named fumonisins were isolated and character- 
ized (7, 27). Fumonisin B1 is the most toxic 
representative of the fumonisins (Figure 3). 
Recently, fumonisins have been linked posi- 
tively to ELEM (39, 46), which is character- 
ized by facial paralysis, nervousness, lameness, 
ataxia, and inability to eat or to drink. The 
principal pathologic lesions include severe ce- 
rebral edema, focal malacia, and liquefaction 
of cerebral white matter. The onset of such 
severe symptoms can be as short as a few 
hours. Fourteen of 18 horses fed a corn-based 
feed contaminated with 37 to 122 ppm of FBI 
developed fatal ELEM (82). Hepatic involve- 
ment often is coincident with central nervous 
system involvement in horses and swine. Two 
reports also have described the development of 
pulmonary edema, hydrothorax, or both in 
swine receiving either intravenous injections of 
FBI or by ingesting feed contaminated by FBI 
(33, 62). In swine, lower doses of FBI resulted 
in a slowly progressive hepatic necrosis; 
higher doses resulted in acute pulmonary 
edema coincident with hepatic toxicity (34). 
That fumonisins are potent inhibitors of sphin- 
gosine biosynthesis in cultured hepatocytes 
(80) has been postulated to account for the 
hepatotoxic (34) and central nervous system 
effects of this toxin (53). Compared with 
-1, however, FBI is much less toxic to 
cultured hepatocytes (29). 
Aside from its acute effects, FBI also ap- 
pears to possess tumor-initiating and tumor- 
promoting activity. Initial studies showed that 
a diet containing culture material inoculated 
with F. monilifonne was carcinogenic in rats 
(36). In later studies with purified FBI, a 
promotional effect on the incidence of 
diethylnitrosamine-induced, y-glutamyltrans- 
peptidase-positive (y-GT+) hepatic foci in rats 
was noted (27). Short-term dietary FBI in- 
duced a high incidence (66%) of HCC (28). 
Metastases to the heart, lungs, or kidneys also 
were observed. Symptoms of hepatic involve- 
ment, such as macronodular cirrhosis and 
cholangiofibrosis, also were observed. 
In a recent study, Gelderblom et al. (29) 
noted that FBI is probably only a modest 
initiator of liver tumors, because y-GT+ foci 
and hepatocellular nodules were observed only 
after prolonged feeding of . l% FBI in rats. 
Those authors (29) postulated that the carcino- 
genic effect of FBI likely involves promotion 
and the selection of initiated hepatocytes, 
events that occur during the postinitiation 
phase of hepatocarcinogenesis. 
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The mechanism of fumonisin carcinogenic- 
ity does not appear to involve interaction with 
DNA. Neither FBI nor FB2  elicited unsche- 
duled DNA repair in primary rat hepatocyte 
cultures treated either in vitro or in vivo (29). 
Therefore, the carcinogenic activity of fumoni- 
sins may be mediated via epigenetic mechan- 
isms, as is the case of peroxisome prolifera- 
tors. 
Research on the health effects of fumonisins 
has essentially only just begun, and informa- 
tion on the mechanism of fumonisin toxicity or 
on the mechanisms underlying species sensi- 
tivity is only beginning to be compiled. More 
information is needed to obtain a fuller under- 
standing of the extent of the adverse effects of 
fumonisins in human and animal health. Be- 
cause corn is a staple in many parts of the 
world and because Fusarium contamination of 
corn is nearly universal, fumonisins likely are 
involved in human toxicoses and other health 
effects. Corn contaminated by Fusarium has 
been epidemiologically associated with human 
esophageal cancer in some regions of South 
Africa (70). 
CONCLUSIONS 
Although much information has been ob- 
tained regarding the action of several classes of 
mycotoxins, future research topics should con- 
tinue to address several areas of critical con- 
cern. For example, the continued development 
of simple, rapid, and more sensitive detection 
methods will aid in efforts to prevent contami- 
nated commodities from reaching the market. 
New kits that allow simple and rapid 
mycotoxin detection without the need for ex- 
pensive equipment or extensive training re- 
cently have been developed. 
More information is needed on decontami- 
nation strategies. Although ammoniation is ef- 
fective for detoxification of AFBI, fumonisins 
apparently are not affected by this treatment 
(80). In addition, little information exists on 
the stability of tricothecenes and ZEN to food 
processing. 
Determination of the actual risk posed to 
humans who consume foods contaminated by 
mycotoxin is of critical concern. Laboratory 
and epidemiological approaches are important 
in addressing this question. In the case of 
AFB1, comparative species studies have been 
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essential to obtain some understanding of the 
mechanisms underlying sensitivity and resis- 
tance to the carcinogenic effects of this 
mycotoxin. Molecular biological approaches 
have begun to provide some information on 
the role of AFBl in mutations in specific 
cancer-causing genes in humans and other 
animals. Mechanism studies on the fumonisins 
will be advanced with the identification of 
appropriate animal models of the toxic effects 
observed in domestic animals. 
New methods to detect specific biomarkers 
in noninvasive samples, such as urine, are 
beginning to be an important tool in measure- 
ment of actual human exposure in populations 
that are particularly at risk. Biomarkers for 
other potentially carcinogenic mycotoxins to 
which humans are exposed, such as fumoni- 
sins, will likewise allow greater determination 
of risk. Identification of potentially synergistic 
risk factors coincident with mycotoxin ex- 
posure, such as other foodbome toxins, infec- 
tious agents, and synthetic chemicals, will also 
be important in these efforts. 
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